Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Source study found

Story checked

Scientists Put Anti-Aging Treatments to the Test – These Ones Actually Changed Biological Age (opens in a new tab)

scitechdaily.com · 2026-09-26

Short answerEvidenceSource

Short answer

Mostly not supported

Mostly not supported.

One claim goes further than the study. 3 other points were not covered by the paper.

  • 1 supported
  • 1 overstated
  • 3 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mostly not supported

One claim overstates the study. One of five checks out. Three claims the study doesn't address.

  • 1 supported
  • 1 overstated
  • 3 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

5 claims in this story

Showing all 5 claimsChoose a verdict to focus the list.

Claim 1 of 5OverstatedThe researchers pooled data from 51 intervention studies and assessed more than 110 DNA methylation biomarkers, including 16 major epigenetic clocks.View evidenceHide evidence

As stated51 intervention studies; more than 110 biomarkers; 16 major clocks

Why this verdict

The profile supports 51 longitudinal interventional studies and 16 epigenetic clocks plus 94 other DNAm biomarkers. That totals 110 DNAm biomarkers, not “more than 110” as stated. The study-count and clock-count portions are supported, but the biomarker-count magnitude is overstated relative to the supplied abstract profile.

1

Study evidence

The authors curated TranslAGE, a harmonized database aggregating 51 public and private longitudinal interventional studies.

“Here we curate TranslAGE, a harmonized database of 51 public and private longitudinal interventional studies”
2

Study evidence

Across the TranslAGE database, the authors report consistent computation of 16 epigenetic clocks and 94 DNAm biomarkers for each included study.

“calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 94 other DNA methylation (DNAm) biomarkers”
Claim 2 of 5Not coveredLifestyle programs, especially exercise combined with a healthy diet, consistently lowered epigenetic age, while supplements generally showed little effect.View evidenceHide evidence

Why this verdict

The abstract-level profile supports a broad claim that lifestyle interventions were among the intervention classes producing strong DNAm biomarker responses. It does not specify exercise combined with healthy diet, does not establish that these programs “consistently lowered epigenetic age,” and does not report that supplements generally had little effect. Those more specific directional and intervention-subtype claims are not verifiable from the abstract profile.

1

Study evidence

Epigenetic clocks trained to predict mortality or pace of aging showed the strongest responses to interventions and produced consistent results with one another across the curated set of interventional studies.

“Using this database, we discover patterns of responsiveness across a variety of interventions”
2

Study evidence

Pharmacological and lifestyle interventions drive the strongest responses among the 94 DNAm biomarkers.

“along with 94 other DNA methylation (DNAm) biomarkers that can help explain the changes observed for each clock”
Claim 3 of 5Not coveredPrescription drugs produced the largest decreases, with the strongest results reported for metformin, semaglutide, and anti-TNF treatments.View evidenceHide evidence

As statedlargest decreases

Why this verdict

The profile supports only the broader finding that pharmacological and lifestyle intervention classes produced some of the strongest DNAm biomarker responses. It does not say prescription drugs produced the largest decreases, nor does it identify metformin, semaglutide, or anti-TNF treatments. The named-drug ranking and “largest decreases” framing are not verifiable at abstract depth.

1

Study evidence

Epigenetic clocks trained to predict mortality or pace of aging showed the strongest responses to interventions and produced consistent results with one another across the curated set of interventional studies.

“Using this database, we discover patterns of responsiveness across a variety of interventions”
2

Study evidence

Pharmacological and lifestyle interventions drive the strongest responses among the 94 DNAm biomarkers.

“along with 94 other DNA methylation (DNAm) biomarkers that can help explain the changes observed for each clock”
Claim 4 of 5Not coveredThe article says the findings were published in Nature Medicine and that younger biomarker readings do not yet prove slower aging, disease prevention, or longer life.View evidenceHide evidence

Why this verdict

The supplied paper profile does not include journal/publication metadata verifying Nature Medicine. The caution that younger biomarker readings do not yet prove slower aging, disease prevention, or longer life is scientifically consistent with the paper’s surrogate-biomarker framing, but that exact limitation is not stated in the abstract-level profile. Therefore the combined publication-venue and caveat claim is not fully verifiable at this depth.

Claim 5 of 5SupportedA Yale-led study tested whether widely studied anti-aging strategies produce consistent changes in biological age using DNA-based blood tests.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the core framing: the paper curated a harmonized database of longitudinal human interventional studies and used DNAm/epigenetic-clock biomarkers to assess responsiveness of aging-related biomarkers to interventions. The supplied profile does not verify the institutional descriptor “Yale-led,” but the scientific substance of the claim is supported at this depth.

1

Study evidence

The authors curated TranslAGE, a harmonized database aggregating 51 public and private longitudinal interventional studies.

“Here we curate TranslAGE, a harmonized database of 51 public and private longitudinal interventional studies”
2

Study evidence

Across the TranslAGE database, the authors report consistent computation of 16 epigenetic clocks and 94 DNAm biomarkers for each included study.

“calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 94 other DNA methylation (DNAm) biomarkers”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • The main clock-level result is that clocks trained to predict mortality or pace of aging showed the strongest and most concordant responses across interventions.

    The story discusses epigenetic age reductions generally, but it does not report the abstract’s specific emphasis on mortality-trained and pace-of-aging-trained clocks being the strongest and mutually consistent.

    From secondary data synthesis; secondary_data / moderator-analysis

  • The paper identifies study population characteristics and study duration as key determinants of DNAm biomarker responsiveness and uses these findings to inform future trial design choices.

    The story’s caveats mention larger/diverse groups and uncertainty about timing/durability, but it does not convey the paper’s affirmative result that population characteristics and duration were modeled as key determinants or that these analyses were used for trial-design guidance.

    From secondary_data / moderator-analysis

  • The paper reports that multi-subscore, “explainable” clocks provide greater specificity and mechanistic insight than single-score clocks.

    This is a distinct abstract-level finding in the paper profile, but it is not reflected in the story claims or listed caveats.

    From secondary_data

4 things the story did carry across
  • The paper’s core resource is TranslAGE, a harmonized database of 51 public and private longitudinal human interventional studies.
  • The paper computed 16 epigenetic clocks plus 94 additional DNAm biomarkers, for a total of 110 DNAm biomarkers, using a standardized cross-study pipeline.
  • The paper reports that pharmacological and lifestyle intervention classes produced the strongest DNAm biomarker responses overall.
  • The paper is a secondary-data synthesis of heterogeneous existing interventional studies, not a newly run randomized intervention trial by the authors.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

6

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify and compare responsiveness of 16 epigenetic clocks across interventions, including concordance among clocks trained for mortality/pace-of-aging outcomes.secondary data synthesisExpand

In plain English

Across a harmonized TranslAGE database of 51 longitudinal interventional studies, the authors computed a consistent set of 16 epigenetic clocks and 94 additional DNAm biomarkers and compared their responsiveness to diverse longevity interventions; clocks trained to predict mortality or pace-of-aging showed the largest and most concordant responses across interventions.

Key findings

  • Epigenetic clocks trained to predict mortality or pace of aging showed the strongest responses to interventions and produced consistent results with one another across the curated set of interventional studies.
  • Pharmacological and lifestyle interventions elicited the strongest responses among the DNAm biomarkers examined.
“Using this database, we discover patterns of responsiveness across a variety of interventions”
2secondary dataCreate and describe TranslAGE: a harmonized database of longitudinal human interventional studies with consistently computed epigenetic clocks and DNAm biomarkers.secondary dataExpand

In plain English

The authors report creation of TranslAGE, a harmonized database that aggregates 51 public and private longitudinal human interventional studies and, for each study, computes a consistent set of 16 epigenetic clocks plus 94 additional DNA methylation (DNAm) biomarkers to enable cross-study comparison of biomarker responsiveness to interventions.

Key findings

  • The authors curated TranslAGE, a harmonized database aggregating 51 public and private longitudinal interventional studies.
  • For every study in TranslAGE, the authors computed a standardized set of 16 epigenetic clocks plus 94 other DNAm biomarkers to enable consistent downstream analyses.
“Here we curate TranslAGE, a harmonized database of 51 public and private longitudinal interventional studies”
What this piece can’t prove

3 further details could not be confirmed from the summary.

3secondary dataCreate and describe TranslAGE: a harmonized database of longitudinal human interventional studies with consistently computed epigenetic clocks and DNAm biomarkers.secondary data processingExpand

In plain English

The authors assembled TranslAGE, a harmonized database of 51 public and private longitudinal interventional human studies and applied a cross-study pipeline to compute a consistent set of 16 epigenetic clocks and 94 additional DNA methylation (DNAm) biomarkers for each study.

Key findings

  • Across the TranslAGE database, the authors report consistent computation of 16 epigenetic clocks and 94 DNAm biomarkers for each included study.
“calculate a consistent set of 16 prominent epigenetic clocks for each study, along with 94 other DNA methylation (DNAm) biomarkers”
What this piece can’t prove
  • Information is limited to the abstract — methodological implementation details needed to assess reproducibility and reusability are not described.
  • Unclear how harmonization handled technical heterogeneity across cohorts (arrays/platforms, batch effects, probe overlap).
4secondary dataAssess responsiveness patterns across 94 other DNAm biomarkers and identify which intervention classes (for example pharmacological vs lifestyle) drive stronger biomarker responses.secondary dataExpand

In plain English

Using a harmonized database (TranslAGE) of 51 longitudinal interventional studies, the authors calculated a consistent panel of 16 epigenetic clocks and 94 additional DNA methylation (DNAm) biomarkers per study and examined responsiveness patterns across interventions. They report that pharmacological and lifestyle intervention classes produce the strongest responses among the 94 DNAm biomarkers, and that study population characteristics and study duration are important determinants of biomarker responsiveness. The 94 DNAm biomarkers are presented as complementary to clocks and can help explain clock changes.

Key findings

  • Pharmacological and lifestyle interventions drive the strongest responses among the 94 DNAm biomarkers.
  • Characteristics of the study population and study duration are key factors determining DNAm biomarker responsiveness.
“along with 94 other DNA methylation (DNAm) biomarkers that can help explain the changes observed for each clock”
What this piece can’t prove
  • Abstract does not describe statistical methods used for multiple-testing control across 94 biomarkers or cross-study synthesis approach (e.g., meta-analysis vs pooled models).
  • Heterogeneity in study interventions, populations, sample collection, and duration across the 51 studies is not detailed, limiting assessment of generalizability.
  • The abstract does not list which of the 94 DNAm biomarkers responded or provide biomarker-level results needed for replication or design of follow-up studies.

1 further detail could not be confirmed from the summary.

5secondary dataModel how study and population characteristics (for example duration, population characteristics) relate to observed DNAm biomarker responsiveness and use these insights to inform future trial design choices.secondary data / moderator-analysisExpand

In plain English

Using a harmonized secondary database (TranslAGE) of 51 longitudinal interventional studies, the authors report that study population characteristics and study duration are key determinants of DNA methylation (DNAm) biomarker responsiveness to longevity interventions, and they translate these associations into trial-design guidance (choice of interventions and biomarker subsets to reduce multiple testing, required duration, population selection and sample size).

Key findings

  • Study population characteristics and study duration are key factors in determining the responsiveness of DNAm biomarkers to interventions.
  • Clocks trained to predict mortality or pace of aging showed the strongest and most consistent responses across interventions.
“the characteristics of the study population and study duration are key factors in determining the responsiveness of DNAm biomarkers to an intervention”
What this piece can’t prove
  • Unclear whether and how authors handled within-study vs between-study variance, dependence across multiple biomarkers measured in the same cohorts, or multiple testing correction across many DNAm biomarkers.

4 further details could not be confirmed from the summary.

6secondary dataEvaluate whether multi-subscore ('explainable') clocks provide greater mechanistic specificity/insight than single-score clocks when assessing intervention responsiveness.secondary dataExpand

In plain English

The authors report that epigenetic clocks that decompose into multiple subscores ("explainable clocks") offer greater specificity and mechanistic insight into how interventions affect DNA methylation–based aging measures than single-score clocks. This conclusion is based on comparative responsiveness analyses across a harmonized set of longitudinal interventional studies using a panel of epigenetic clocks and additional DNAm biomarkers.

Key findings

  • Clocks with multiple subscores ('explainable clocks') provided specificity and greater mechanistic insight into the responsiveness of interventions compared with single-score clocks.
“clocks with multiple subscores (that is 'explainable clocks') provide specificity and greater mechanistic insight into the responsiveness of interventions than single-score clocks”
What this piece can’t prove
  • Abstract does not specify which clocks are classified as 'explainable' versus single-score, nor the exact composition or derivation of subscores.

3 further details could not be confirmed from the summary.

Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 36 candidate papers

And 30 more candidates considered.